Showing results (51-60 of 131) with videos related to

Sort By:
Pageof 14
The Journal of Headache and Pain|September 11, 2020
Burden of migraine among Japanese patients: a cross-sectional National Health and Wellness SurveyShoji Kikui, Yirong Chen, Hiroshi Todaka, et al.
Headache|May 15, 2021
Phase 2 randomized placebo-controlled study of lasmiditan for the acute treatment of migraine in Japanese patientsFumihiko Sakai, Takao Takeshima, Gosuke Homma, et al.
BMJ Open|November 30, 2022
Comorbidities in patients with migraine in Japan: a cross-sectional study using data from National Health and Wellness SurveyShoji Kikui, Yirong Chen, Ken Ikeda, et al.
Rinsho Shinkeigaku = Clinical Neurology|June 21, 2021
[A case of suspected migraine with aura: transient cortical venous dilatation visualized by susceptibility-weighted imaging]Shinichi Wada, Koji Tsuzaki, Hanako Sugiyama, et al.
Neurology and Therapy|April 6, 2024
Clinical Evaluation After Discontinuation of Galcanezumab in Japanese Patients with Episodic and Chronic Migraine: Analysis of a Randomized, Placebo-Controlled Trial and Open-label Extension StudyTakao Takeshima, Hikaru Doi, Satomi Ooba, et al.
Scientific Reports|September 18, 2024
Efficacy of galcanezumab in migraine central sensitizationDaisuke Danno, Noboru Imai, Shigekazu Kitamura, et al.
Biochemical and Biophysical Research Communications|December 6, 2005
Novel cytoprotective mechanism of anti-parkinsonian drug deprenyl: PI3K and Nrf2-derived induction of antioxidative proteinsKazuhiro Nakaso, Chiharu Nakamura, Hiromi Sato, et al.
Cephalalgia : an International Journal of Headache|November 7, 2019
The relation between emotion regulation and migraine: A cross-cultural study on the moderating effect of cultureJohanna Wolf, Daisuke Danno, Takao Takeshima, et al.
FEBS Letters|July 2, 2003
PI3K is a key molecule in the Nrf2-mediated regulation of antioxidative proteins by hemin in human neuroblastoma cellsKazuhiro Nakaso, Hidetaka Yano, Yoko Fukuhara, et al.
Neurology and Clinical Neuroscience|November 8, 2016
Effectiveness and safety of an extended-release tablet of sodium valproate for the prophylactic treatment of migraine: Postmarketing surveillance in JapanTakao Takeshima, Norihiro Suzuki, Yasuhiko Matsumori, et al.
Pageof 14